NextGen Biomed 2025

Proteins, Antibodies & ADCs
Panel Discussion: What Is The Next Game Changer In Antibody Engineering?

Moderator: Karen Silence, Head Preclinical Product Development, ArgenX
Panellists include Berit Olsen Krogh, Senior Research Fellow; and Lundbeck Andrew Buchanan, Principal Scientist, AstraZeneca

Peptides
Roundtable: Regulatory Insights On Bringing A Peptide To Human Trials

Moderator: Paul Reid, Co-Founder & Chief Scientific Officer, Celtic Bio

Oligonucleotides
Workshop: Development Of Targeted Delivery Systems

Two Presentations, followed by a Panel Discussion on 'The Next Chapter Of Oligonucleotide Delivery'
Moderator: Steve Hood, Senior Director, Oligonucleotide ADME Strategy, GSK

Sustainability in Tides & Biologics
Panel Discussion: Navigating The Paradigm Shift Towards Greener Approaches

Moderator: Walter Cabri, Full Professor of Organic Chemistry, University of Bologna
Panellists include Daniel Sejer Pedersen, Chemical Development Specialist CMC API Development, Novo Nordisk;
Anna Maria Papini, Full Professor & Group Leader, University of Florence;
Louis Diorazio, Senior Principal Scientist, New Modalities, AstraZeneca;
Alessandra Tolomelli, Associate Professor, University of Bologna

Immunotherapy & Immuno-oncology
Presentation: How The RNA Technologies Could Help To Prevent Infectious Diseases And Could Be Applied To Various Chronic Disease Immunotherapies?

Presented by: Daniel Larocque, Innovation Lead, Innovation and Emerging Science, Sanofi

Anna Perdrix

Founder & Co-Chief Executive Officer,

Sixfold Bioscience

Fernando Albericio

Professor,

University of KwaZulu-Natal

Joel Richard

Chief Development Officer,

Enterome

Kelly Loyet

Distinguished Scientist,

Genentech

Livija Deban

Chief Scientific Officer,

Prokarium

Maria Koufali

Director,

UK Vaccine Innovation Pathway

Marta Amaral

Group Head High Throughput Protein Engineering in Large Molecules Research,

Sanofi

Martina Ochs

Project Leader,

CEPI

Philip Beer

Chief Scientific Officer,

Step Pharma

Rick Hibbert

Vice President & Head of CMC Science & Technologies,

Genmab

Sudhir Agrawal

President & Founder,

ARNAY Sciences

Tristan Vaughan

Vice President Protein Engineering,

Immunocore

Aaron John Balana

Scientist III,

Genentech

Aikaterini Gatsiou

Assistant Professor,

Lancaster University

Ajan Reginald

Chief Executive Officer,

Roquefort THerapeutics PLC

Alain Wagner

Director,

Strasbourg University

Alastair Lawson

Vice President and Immunology Fellow,

UCB

Alessandra Tolomelli

Associate Professor,

University of Bologna

Alessandro Gori

Group leader,

National Research Council of Italy

Alexandria Cogdill

Head of Strategic Initiatives, Global Business Development,

Daiichi Sankyo, Inc

Alexey Rak

Head of Bio Structure and Biophysics,

Sanofi

Álvaro Enríquez García

Medicinal chemist,

Eli Lilly

Amita Vaidya

Principal Scientist,

Sanofi

Ammar Ahmed

Senior Scientist,

Imperial College London

Amy Li

Director, Drug Discovery,

T-Therapeutics Ltd

Andreas Reichel

Vice President, Head PMS,

Bayer AG

Andreas Midbøe Hoff

Head of In Silico & AI Department,

Nykode

Andrew Slee

Chief Operating Officer,

Protagenic Therapeutics

Andrew Jamieson

Professor,

University of Glasgow

Andrew Buchanan

Scientist,

AstraZeneca

Andri Vasou

Senior Research Scientist,

Bioarchitech

Aneesh Karatt-Vellatt

CoFounder & CSO,

Maxion therapeutics

Anna Hine

Professor of Protein Engineering,

Aston University

Anna Maria Papini

Full Professor and Group leader of PeptLab,

University of Florence (Italy)

Annelise Vuidepot

Chief Technology Officer,

Immunocore

Ash Otter

Principal Investigator, Emerging Pathogen Serology,

UKHSA

Baldur Sveinbjørnsson

Chief Scientific Officer,

Lytix Biopharma

Bassam Hallis

Deputy Director of Research and Evaluation,

ukhsa.gov.uk

Benjamin Lindner

Data Scientist,

Boehringer Ingelheim RCV GmbH & Co KG

Berit Olsen Krogh

Senior Research Fellow,

Lundbeck

Bernard Maillere

Head of laboratory,

CEA

Bjorn Onfelt

Professor of Applied Physics,

Royal Institute of Technology

Brian Schanen

Global Head,

Sanofi

Bryce Nelson

Head Protein and Antibody Engineering,

Orion

Callum Scott

Head of Development,

Scancell

Carla Vinals

Vice President, Global Regulatory Product Strategy,

Moderna Therapeutics

Carol Sze Ki Leung

Senior Immunologist,

Ludwig Institute, Oxford University

Caroline Lonez

R&D Associate Director,

Celyad

Charlotte Vernhes

Scientific and Medical Affairs Director,

Vaccines Europe

Chris Hart

Chief Executive Officer,

Creyon Bio

Christian Garde

Director,

Evaxion Biotech

Christopher Scott

Professor,

Queen's University Belfast

Christopher Coxon

Senior Lecturer, Medicinal Chemistry,

THE UNIVERSITY OF EDINBURGH

Dan Swerdlow

Senior Director,

GSK

Dan Hardy

Chief Executive Officer,

Microsol Ltd

Daniel Larocque

Innovation Leader,

Sanofi Vaccines

Daniel Fonseca

Senior Scientist,

Immunocore

Daniel Sejer Pedersen

Specialist,

Novo Nordisk A/S

Darko Skegro

Associate Director,

Novartis

David Craik

Professor,

The University of Queensland

David Evans

Chief Scientific Officer,

Sirnaomics

David Brockwell

Professor,

University of Leeds

David Pejoski

Cofounder, Co-CEO, COO, Board Member,

Adoram Therapeutics

David Wraith

Professor of Immunology, Director of the Institute of Immunology and Immunotherapy,

University of Birmingham

Denise Steckel

Head of Clinical Collaborations Development,

Genentech

Ed Tate

Professor,

Imperial College London

Eef Dirksen

Group Leader,

Byondis B.V.

Elisa Marelli

Research Scientist,

Scancell

Emma Grant

Senior Analytical Development Scientist,

Immunocore

Emma Stanley

Director, Program Lead - Head of Antibody Discovery,

Mestag Therapeutics

Erik Vernet

Vice President - Scientific Data Registration,

Novo Nordisk

Fazel Shabanpoor

Lab Head Peptide And Oligonucleotide Therapeutics,

The Florey Institute of Neuroscience and Mental Health

Felix Schumacher

Program Leader Targeted Therapeutics,

Hoffmann La Roche Ltd

Francisca Wollerton

Senior Director of Protein Engineering and Novel Modalities,

AstraZeneca

Gabriel Wong

Senior Director Physician, Clinical Research, Immunology,

AstraZeneca

Gal Gur

VP Business Development,

Anima Biotech

Georgios Skretas

Director, Institute for Bioinnovation,

Biomedical Sciences Research Center "Alexander Fleming"

Giulio Russo

Senior Scientist,

Merus NV

Hans Melo

Chief Executive Officer,

Menten Biotechnology Labs

Hans Van Der Vliet

Chief Scientific Officer,

LAVA Therapeutics

Helen Bright

Chief Scientific Officer,

Centauri Therapeutics

Helene Kaplon

Translational Scientist,

Servier

Henry Maun

Staff Scientist,

Genentech

Hester Van Zeeburg

PM immunomonitoring,

Mendus AB

Ian Hamley

Professor of Physical Chemistry,

University of Reading

Ijeoma Uchegbu

Professor of Pharmaceutical Nanoscience,

University College London

Immanuel Lerner

Chief Executive Officer,

Pepticom

Isabelle Sermadiras

Associate Principal Scientist,

AstraZeneca

Iulia Oita

CMC manager,

Ziphius Vaccines

Janos Tibor Kodra

Principal Scientist,

Novo Nordisk

Jean Ge

Patent Attorney,

Wolf Greenfield

Jenny Fitting

Head of AAV and Protein Science,

Bayer

John Maher

Chief Scientific Officer,

Leucid Bio

Jonathan Kwok

Chief Executive Officer,

Infinitopes

Joost Uitdehaag

Head of Biology,

Crossfire Oncology

Jörg Wischhusen

Professor,

University Hospital Würzburg

Jutta Eichler

Professor,

University of Erlangen-Nurnberg

Karen Silence

Head Preclinical Product Development,

Argenx BVBA

Kate Smith

Senior Director, Head of UK Protein and Cell Sciences,

GSK

Kerry Chester

Professor,

UCL

Kevin Fitzgerald

Chief Scientific Officer,

Epsilogen

Kevin Maskell

Research Director,

Bioarchitech

Kirsty Crame

Vice President Clinical Strategy & Development,

Medigene AG

Knud Jørgen Jensen

Professor,

Copenhagen University

Komal Kedia

Associate Principal Scientist,

Merck US

Kuda Muchandibaya

Lecturer for Supply Chain Management & Logistics,

Rhine-Waal University of Applied Sciences

Laura Starkie

Director,

UCB

Laura Collins

Director Bioinformatics,

Immunocore

Leonardo De Maria

Principal Scientist,

AstraZeneca

Louis Diorazio

Senior Principal Scientist,

AstraZeneca

Lucia Ferrazzano

Junior Assistant Professor,

University of Bologna

Luis Gómez-Morales

Scientific Project Manager,

Pepkon

Mads Hald Andersen

Professor, VP,

IO Biotech

Malin Lemurell

Executive Director & Head of Medicinal Chemistry CVRM Biopharmaceuticals R&D,

AstraZeneca

Mani Mudaliar

Director, Quantitative Biomarkers,

Exscientia

Marc Vendrell

Professor of Translational Chemistry,

University of Edinburgh

Maria Fawaz

Associate Principal Scientist,

Merck & Co., Inc., Kenilworth, New Jersey, U.S.A.

Maria DeBruin

Director, Analytical Research and Development,

MSD

Marie McAvoy

Chief Scientific Officer,

Nanosyrinx

Marina Fedorova

Scientific Investigator,

GSK

Mark Eccleston

Chief Executive Officer,

ValiRx Plc.

Mathieu Cinier

Scientific Director,

Affilogic

Matthew Burrell

Associate Director,

AstraZeneca

Mattias Malm

Senior Scientist,

Ferring Pharmaceuticals

Micaela Graglia

Analytical Chemist, Molecular Design,

Silence Therapeutics

Michael Dyson

Vice President,

Ichnos SA

Michael Delaney

Principal Scientist,

NovoNordisk

Michal Shoshan

Founder & Chief Executive Officer,

metaLead Therapeutics AG

Mihaela Bozic

Scientist,

T-Therapeutics

Mikhail Kuravskiy

Principal Scientist,

UCB

Morten Lindow

RNAHub Founder & Mission Lead,

Roche

Nadim Akhtar

Senior Principal Scientist, New Modalities,

AstraZeneca

Nazneen Dewji

Chief Executive Officer,

Cenna Biosciences

Nesrine Chakroun

Associate Director,

Merus NV

Norbert Furtmann

Sanofi,

Head of AI Innovation NANOBODY® Platform

Obinna Ubah

Principal Scientist,

Elasmogen Limited

Owen Vickery

Associate Principal Scientist in augmented biologics,

Astrazeneca

Patricia Alves

Head of the Sanofi Satellite Lab & Coordinator of Analytical Services Unit and Mass Spectrometry Unit,

Instituto de Biologia Experimental e Tecnológica

Paul Wassmann

Senior Principal Scientist,

Novartis AG

Paul Reid

Chief Scientific Officer,

Celtic Biotech

Paul Skipp

Professor of Proteomics,

University of Southampton

Pawel Stocki

Vice President R&D,

Ossianix

Pete Gough

Chief Scientific Officer,

Nimble Therapeutics

Peter Ellmark

CSO,

Alligator Bioscience

Peter Sondermann

CEO,

Tacalyx GmbH Privacy Policy Imprint

Prasun Chakraborty

Chief Executive Officer and Founder,

Genevation LTD

Rajika Perera

Chief Executive Officer,

Poseidon LLC

Raymond Tesi

President & Chief Executive Officer,

InMune Bio

Reeta Daswani

Senior Scientist,

Sixfold

Rita Martello

Scientific Director, NBE DMPK Lead,

Merck KGaA

Rodrigo Abreu

Principal Scientist,

LifeArc

Sagar Kathuria

Biophysicist - Protein Engineering,

Sanofi

Sandeep Talapatra

Science Lead - Protein Science,

GSK

Sandor Batkai

Co-founder, Head of Medical Research and Intelligence,

Cardior Pharmaceuticals GmbH

Sandra Tremmel

Microbiology Engineer, Pharma Technical Product Quality- Analytical Sciences,

F. Hoffmann-La Roche Ltd

Sandrien Janssens

CMC Director,

Mosanna Therapeutics

Santiago Parpal

Principal Scientist,

Sprint Bioscience

Sara Mangsbo

Chief Innovation Officer,

Ultimovacs

Sarah Stuart

HTC Team Leader,

GSK

Sarah Hindson

Senior Scientist,

GSK

Saul Martinez Montero

Senior Director, RNA Therapeutics,

Dyne Therapeutics

Saurabh Sen

Associate Director, Cell Line Development, Mammalian Platform Biologics,

Sanofi

Simon Krah

Associate Director,

Merck Healthcare KgaA

Simon Plyte

Chief Scientific Officer,

Biomunex Pharmaceuticals

Simon Hufton

Section Head Molecular Immunology, Division of Biotherapeutics,

MHRA

Simone Friedrich

Director Antibody Discovery & Development,

iOmx Therapeutics

Sonia Macia

Chief Medical Officer,

Aromics Therapeutics

Sophia Karagiannis

Professor of Translational Cancer Immunology and Immunotherapy,

King's College London

Sritama Bose

Head of Chemistry Research and Innovation,

Nucleic Acid Therapy Accelerator MRC

Stefan Z

Senior Director - Global Head of Antibody Discovery & Protein Engineering,

Merck Kgaa Darmstadt Germany

Stephen Miller

Principal Scientist,

Genentech

Steve Hood

Senior Director, Oligonucleotide ADME Strategy, DMPK,

GSK

Steven Schmitt

Co-Founder & Chief Executive Officer,

Myria Biosciences

Stine Friis Thorsen

Director Clinical Development,

Evaxion Biotech

Sue Charlton

Head of Clinical Evaluation,

UKHSA

Talip Ucar

Senior Director - AI Research,

AstraZeneca

Tatyana Ponomaryov

Principal Scientist,

Plasticell Limited

Thomas Kraft

Principal Scientist,

Roche

Tim Hickling

Immunogenicity Expert Scientist,

Roche

Tomáš Hanke

Professor,

University of Oxford

Tomasz Witkos

Associate Director,

AstraZeneca

Trevor Smith

Vice President,

Inovio

Vaios Karanikas

Biomarker Experimental Medicine Leader, Oncology,

Hoffmann La Roche Ltd

Vincent Dewar

Head of Immunoassay,

GSK

Vincenzo de Filippis

Associate Professor Biochemistry,

University of Padova

Vladimir Gligorijević

Senior Director, AI/ML,

Genentech

Walter Cabri

Professor,

University of Bologna

Wen Chang

Associate Vice President Discovery and Early Development,

AcuraStem

Will Nesbit

Director - Process Chemistry, CMC,

Bicycle Therapeutics

Wolfgang Koch

Senior Scientist,

F-star Therapeutics Inc

Xiao Wan

Senior Researcher - Biology,

Nucleic Acid Therapy Accelerator (NATA)

Yann Abraham

Associate Director AI for Single Cell,

Johnson & Johnson Innovative Medicine

Yi Yang

Principal Scientist,

Ferring Pharmaceuticals A/S

Zahra Rattray

Senior Lecturer,

University of Strathclyde

The 1-2-1s are the best thing about Oxford Global events, well organised and good number of relevant contacts. Good high level contacts from big companies.

Advanced Therapies Specialist Team Leader,
Genscript

Biologics 2024 has been one of the best events I have attended so far in my career.

Territorial Sales Manager UK,
ACROBiosystems Co., Ltd.

Impressed by the effort to bring people together.

Business Development Director,

Bioassay

Nice set-up, with good support for exhibitors

Director of Client Relations,

ImmunoPrecise

Interested in Sponsoring NextGen Biomed?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

In-Person Services Digital Marketing Services